SCHEMBL7974476

SCHEMBL7974476

CCOc1ccc(-c2nc3ncn(Cc4ccccc4)c3c(=O)[nH]2)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GUSB P08236 1/20 0.56
ALDH1A1 P00352 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
HPGD P15428 2/20 0.52
KMT2A Q03164 1/20 0.51
CSNK2A2 P19784 1/20 0.45
CSNK2B P67870 1/20 0.45
CSNK2A1 P68400 1/20 0.45
BRD4 O60885 1/20 0.44
GAA P10253 2/20 0.44
ADORA2B P29275 1/20 0.43
SIRT2 Q8IXJ6 1/20 0.43
SIRT1 Q96EB6 1/20 0.43
PRMT5 O14744 4/20 0.43
KDM4E B2RXH2 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987767 0.92 SMN1; SMN2 (0.50) GUSBALDH1A1SMN1; SMN2HPGDKMT2A
Morpholine SCHEMBL7991505 0.91 KMT2A (0.55) GUSBALDH1A1SMN1; SMN2HPGDKMT2A
SCHEMBL7985230 0.90 ALDH1A1 (0.53) GUSBALDH1A1SMN1; SMN2HPGDKMT2A
SCHEMBL7974404 0.89 SMN1; SMN2 (0.49) GUSBALDH1A1SMN1; SMN2HPGDKMT2A
SCHEMBL7975265 0.88 SMN1; SMN2 (0.61) ALDH1A1SMN1; SMN2HPGDKMT2ABRD4
SCHEMBL7985702 0.86 HPGD (0.50) GUSBALDH1A1SMN1; SMN2HPGDKMT2A
SCHEMBL7975129 0.85 SMN1; SMN2 (0.56) ALDH1A1SMN1; SMN2HPGDKMT2ABRD4
SCHEMBL7984453 0.85 ALDH1A1 (0.56) GUSBALDH1A1SMN1; SMN2HPGDKMT2A
SCHEMBL7974505 0.84 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2HPGDKMT2ABRD4
SCHEMBL7988556 0.84 SMN1; SMN2 (0.58) GUSBALDH1A1SMN1; SMN2HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed